NOVONIX Commences Process for Nasdaq Listing

NOVONIX Limited (ASX: NVX, OTCQX: NVNXF) (“NOVONIX” or “the Company”), today announces the commencement of the process to list its securities on the Nasdaq Stock Market (‘Nasdaq’). As announced to the Australian Securities Exchange ("ASX") on 10 May 2021, NOVONIX has been exploring a secondary listing of its securities on Nasdaq. In the first stage of the process, NOVONIX has filed a registration statement, Form 20-F, with the U.S. Securities and Exchange Commission (“SEC”). The U.S. listing is expected to take place after the SEC and Nasdaq have completed their review process and upon effectiveness of the registration statement.

The securities will take the form of a Level II American Depository Receipt (ADR) program and will complement the existing primary listing of NVX shares on the Australian Securities Exchange ("ASX"). An ADR is a negotiable receipt, resembling a stock certificate that is issued by a United States depositary bank appointed to evidence one or more American Depositary Shares.

The Company intends to appoint The Bank of New York Mellon ("BNY Mellon") to establish the Level II ADR Program and to act as the ADR depositary, custodian and registrar.

Establishing this program is part of an ongoing strategy to expand NOVONIX’s reach to investors in the United States and make the Company’s securities potentially eligible as a direct investment for North American institutions and fund managers.

Under the program, NOVONIX expects to begin trading on Nasdaq under the ticker symbol “NVX”. The establishment of the program by NOVONIX is not a public offering or issuance of new NOVONIX ordinary shares. Under the Level II program, the ADRs will be based on NOVONIX’s ordinary shares currently on issue. Each ADR will represent four (4) fully paid ordinary shares of NOVONIX. No final decision has been made by the SEC in respect of the proposed Nasdaq listing and there can be no assurance as to the occurrence, timing and/or completion of such a listing and effectiveness of the registration statement. NOVONIX'S ordinary shares are currently listed on the ASX under the symbol “NVX” where the securities will continue to trade following any Nasdaq listing.